Study on the mechanism of apatinib reversing tamoxifen resistance in breast cancer

被引：0
|
作者：
Li, Q. [1 ]
Zhu, W. [1 ]
Hao, L. [1 ]
机构：
[1] Hebei Gen Hosp, Oncol Dept 4, Shijiazhuang, Hebei, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.168
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15P
引用
收藏
页码：S249 / S249
页数：1
相关论文
共 50 条
  • [41] Role of endothelin-1 in tamoxifen resistance: Mechanism for a new possible treatment strategy in breast cancer
    Namazi, Soha
    Fard, Shirin Ardeshir Rouhani
    Abedtash, Hamed
    MEDICAL HYPOTHESES, 2008, 70 (01) : 109 - 111
  • [42] Functional combination of resveratrol and tamoxifen to overcome tamoxifen-resistance in breast cancer cells
    Radwan, Aliaa M.
    Abosharaf, Hamed A.
    Sharaky, Marwa
    Abdelmonem, Rehab
    Effat, Heba
    ARCHIV DER PHARMAZIE, 2024,
  • [43] Splice variant profiling in relation to tamoxifen resistance in breast cancer
    Zhang, L. D.
    Chan, Y. K.
    Ip, Y. C.
    Tsang, W. H.
    Cheung, Y. N.
    Wong, S. Y.
    Khoo, U. S.
    EJC SUPPLEMENTS, 2010, 8 (05): : 62 - 62
  • [44] MOLECULAR MECHANISMS OF RESISTANCE TO TAMOXIFEN THERAPY IN BREAST-CANCER
    MORROW, M
    JORDAN, VC
    ARCHIVES OF SURGERY, 1993, 128 (11) : 1187 - 1191
  • [45] Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer
    Das, Chandan Kanta
    Parekh, Aditya
    Parida, Pratap Kumar
    Bhutia, Sujit Kumar
    Mandal, Mahitosh
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2019, 1866 (06): : 1004 - 1018
  • [46] Tamoxifen resistance and epigenetic modifications in breast cancer cell lines
    Badia, Eric
    Oliva, Joan
    Balaguer, Patrick
    Cavailles, Vincent
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (28) : 3035 - 3043
  • [47] Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer
    Hany N. Azzam
    Marwa O. El-Derany
    Sara A. Wahdan
    Reham M. Faheim
    Gouda K. Helal
    Ebtehal El-Demerdash
    Scientific Reports, 12
  • [48] Alternative splicing of ALDOA confers tamoxifen resistance in breast cancer
    Yu, Shiyi
    Wu, Rui
    Si, Yue
    Fan, Zhehao
    Wang, Ying
    Yao, Chang
    Sun, Rongmao
    Xue, Yaji
    Chen, Yongli
    Wang, Zheng
    Dong, Shuangshuang
    Wang, Ning
    Ling, Xinyue
    Liang, Zhengyan
    Bi, Caili
    Yang, Yi
    Dong, Weibing
    Sun, Haibo
    ONCOGENE, 2024, 43 (39) : 2901 - 2913
  • [49] Role of the androgen receptor in Tamoxifen Resistance in breast cancer.
    De Amicis, F.
    Cui, Y.
    Parra, I
    Ando, S.
    Fuqua, S. A. W.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S37 - S38
  • [50] Acquired tamoxifen resistance sensitises breast cancer cells to bisphosphonates
    Lymperatou, Dionysia
    Smith, Christopher
    Jiang, Wen Guo
    Evans, Bronwen
    Hiscox, Stephen
    CANCER RESEARCH, 2016, 76
12345